论文部分内容阅读
目的通过比较辛伐他汀治疗心绞痛和常规方法治疗心绞痛的疗效,探究辛伐他汀治疗心绞痛的有效性和安全性。方法临床资料为我院自2010年03月至2010年09月收治的80例心绞痛患者,按照简单随机分组的方法分为治疗组和对照组,每组40人,采用对照分析的方法进行统计分析。结果治疗组40例中疗效显著36例,有效4例,无效0例,对照组40例中疗效显著10例,有效26例,无效4例。结论辛伐他汀在治疗心绞痛中疗效显著,并且具毒副作用小的特点,值得临床推广使用。
Objective To compare the efficacy of simvastatin in the treatment of angina pectoris and conventional methods to investigate the efficacy and safety of simvastatin in the treatment of angina pectoris. Methods The clinical data of 80 patients with angina pectoris treated in our hospital from March 2010 to September 2010 were divided into treatment group and control group according to a simple randomized method. Each group of 40 patients were analyzed by the method of comparative analysis . Results Among the 40 cases in the treatment group, 36 cases were significantly effective, 4 cases effective and 0 ineffective. In the control group, 40 cases showed significant effect in 10 cases, effective in 26 cases and ineffective in 4 cases. Conclusion Simvastatin has significant curative effect in the treatment of angina pectoris and has the characteristics of small side effects and is worthy of clinical promotion.